Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Kerridge

Showing results (91-100 of 308) with videos related to

Pageof 31
Sort By:
Journal of Law and Medicine|October 25, 2014
The emergence and popularisation of autologous somatic cellular therapies in Australia: therapeutic innovation or regulatory failure?Alison K McLean, Cameron Stewart, Ian Kerridge
The American Journal of Bioethics : AJOB|September 23, 2016
More Than One Way to Be Global: Globalization of Research and the Contest of IdeasPaul H Mason, Wendy Lipworth, Ian Kerridge
Internal Medicine Journal|September 15, 2020
Understanding the ethical implications of the rituals of medicineMark H Arnold, Paul Komesaroff, Ian Kerridge
Internal Medicine Journal|January 21, 2022
Should COVID-19 vaccinations be mandatory?Paul A Komesaroff, David Isaacs, Ian Kerridge
Journal of Bioethical Inquiry|June 17, 2020
Symposium Lead Essay-Conflict of Interest: Opening Up New TerritoriesMiriam Wiersma, Wendy Lipworth, Paul Komesaroff, et al.
The Medical Journal of Australia|April 5, 2012
Time for the Pharmaceutical Benefits Advisory Committee to set its own agendaWendy L Lipworth, Ian Kerridge, Richard O Day
BMJ (Clinical Research Ed.)|December 3, 2011
How clinical and research failures lead to suboptimal prescribing: the example of chronic goutWendy Lipworth, Ian Kerridge, Jonathan Brett, et al.
Journal of Evaluation in Clinical Practice|November 19, 2016
Challenges to the validity of using medicine labels to categorize clinical behavior: An empirical and normative critique of "off-label" prescribingNarcyz Ghinea, Ian Kerridge, Miles Little, et al.
EMBO Reports|December 17, 2008
Managing the unimaginable. Regulatory responses to the challenges posed by synthetic biology and synthetic genomicsGabrielle N Samuel, Michael J Selgelid, Ian Kerridge
Current Opinion in Molecular Therapeutics|October 2, 2010
The ethics of gene therapy: balancing the risksClaire T Deakin, Ian E Alexander, Ian Kerridge
Pageof 31

Showing results (91-100 of 308) with videos related to

Sort By:
Pageof 31
Journal of Law and Medicine|October 25, 2014
The emergence and popularisation of autologous somatic cellular therapies in Australia: therapeutic innovation or regulatory failure?Alison K McLean, Cameron Stewart, Ian Kerridge
The American Journal of Bioethics : AJOB|September 23, 2016
More Than One Way to Be Global: Globalization of Research and the Contest of IdeasPaul H Mason, Wendy Lipworth, Ian Kerridge
Internal Medicine Journal|September 15, 2020
Understanding the ethical implications of the rituals of medicineMark H Arnold, Paul Komesaroff, Ian Kerridge
Internal Medicine Journal|January 21, 2022
Should COVID-19 vaccinations be mandatory?Paul A Komesaroff, David Isaacs, Ian Kerridge
Journal of Bioethical Inquiry|June 17, 2020
Symposium Lead Essay-Conflict of Interest: Opening Up New TerritoriesMiriam Wiersma, Wendy Lipworth, Paul Komesaroff, et al.
The Medical Journal of Australia|April 5, 2012
Time for the Pharmaceutical Benefits Advisory Committee to set its own agendaWendy L Lipworth, Ian Kerridge, Richard O Day
BMJ (Clinical Research Ed.)|December 3, 2011
How clinical and research failures lead to suboptimal prescribing: the example of chronic goutWendy Lipworth, Ian Kerridge, Jonathan Brett, et al.
Journal of Evaluation in Clinical Practice|November 19, 2016
Challenges to the validity of using medicine labels to categorize clinical behavior: An empirical and normative critique of "off-label" prescribingNarcyz Ghinea, Ian Kerridge, Miles Little, et al.
EMBO Reports|December 17, 2008
Managing the unimaginable. Regulatory responses to the challenges posed by synthetic biology and synthetic genomicsGabrielle N Samuel, Michael J Selgelid, Ian Kerridge
Current Opinion in Molecular Therapeutics|October 2, 2010
The ethics of gene therapy: balancing the risksClaire T Deakin, Ian E Alexander, Ian Kerridge
Pageof 31